000 01244 a2200337 4500
005 20250515040521.0
264 0 _c20061128
008 200611s 0 0 eng d
022 _a1525-4135
024 7 _a10.1097/01.qai.0000234089.41785.c8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aL'homme, Rafaƫlla F A
245 0 0 _aBrief report: enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy women.
_h[electronic resource]
260 _bJournal of acquired immune deficiency syndromes (1999)
_cOct 2006
300 _a193-6 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aDrug Resistance, Viral
650 0 4 _aEnzyme Induction
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aNevirapine
_xpharmacokinetics
650 0 4 _aPilot Projects
700 1 _aDijkema, Tim
700 1 _avan der Ven, Andre J A M
700 1 _aBurger, David M
773 0 _tJournal of acquired immune deficiency syndromes (1999)
_gvol. 43
_gno. 2
_gp. 193-6
856 4 0 _uhttps://doi.org/10.1097/01.qai.0000234089.41785.c8
_zAvailable from publisher's website
999 _c16526209
_d16526209